Dr. Mohamed’s previous research has focused primarily on exploring social, cognitive, and affective factors influencing patients’ coping with and adjustment to cancer diagnosis and treatment. Guided by a self-regulation theoretical framework, the focus of her current research is twofold: the assessment of cognitive and affective factors influencing treatment decision making and the development of applied psychosocial interventions to enhance treatment decision making, quality of life, and post-treatment healthcare among both prostate and bladder cancer patients and their family caregivers. Dr. Mohamed’s research is funded by a Career Development Award from the American Cancer Society (ACS), an Idea Development Award from the Department of Defense (DOD) and the National Cancer Institute.
Fellowship, The Cancer Institute of New Jersey
PhD, Free University, Germany
Examining Unmet Needs Among Bladder Cancer Patients
Aims: To examine unmet informational, physiological and health-related unmet needs among muscle invasive bladder cancer.
An Educational Intervention for Bladder Cancer Patients
Aims: To examine the feasibility of an educational intervention to enhance bladder cancer treatment decision making among newly diagnosed bladder cancer patients.
Galsky MD, Stensland K, Sfakianos JP, Mehrazin R, Diefenbach M, Mohamed N, Tsao CK, Boffetta P, Wiklund P, Oh WK, Mazumdar M, Ferket B. Comparative Effectiveness of Treatment Strategies for Bladder Cancer With Clinical Evidence of Regional Lymph Node Involvement. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Aug; 34(22).
Mohamed NE, Gilbert F, Lee CT, Sfakianos J, Knauer C, Mehrazin R, Badr H, Wittmann D, Downs T, Berry D, Given B, Wiklund P, Steineck G. Pursuing Quality in the Application of Bladder Cancer Quality of Life Research. Bladder cancer (Amsterdam, Netherlands) 2016 Apr; 2(2).
Benn EK, Alexis A, Mohamed N, Wang YH, Khan IA, Liu B. Skin Bleaching and Dermatologic Health of African and Afro-Caribbean Populations in the US: New Directions for Methodologically Rigorous, Multidisciplinary, and Culturally Sensitive Research. Dermatology and therapy 2016 Dec; 6(4).
Mohamed NE, Pisipati S, Lee CT, Goltz HH, Latini DM, Gilbert FS, Wittmann D, Knauer CJ, Mehrazin R, Sfakianos JP, McWilliams GW, Quale DZ, Hall SJ. Unmet informational and supportive care needs of patients following cystectomy for bladder cancer based on age, sex, and treatment choices. Urologic oncology 2016 Dec; 34(12).
Bijlani A, Hebert AE, Davitian M, May H, Speers M, Leung R, Mohamed NE, Sacks HS, Tewari A. A Multidimensional Analysis of Prostate Surgery Costs in the United States: Robotic-Assisted versus Retropubic Radical Prostatectomy. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2016 Jun; 19(4).
Mohamed NE, Chaoprang Herrera P, Hudson S, Revenson TA, Lee CT, Quale DZ, Zarcadoolas C, Hall SJ, Diefenbach MA. Muscle invasive bladder cancer: examining survivor burden and unmet needs. The Journal of urology 2014 Jan; 191(1).
Pollard ME, Levinson AW, Shapiro EY, Cha DY, Small AC, Mohamed NE, Badani KK, Gupta M. Comparison of 3 upper tract anticarcinogenic agent delivery techniques in an ex vivo porcine model. Urology 2013 Dec; 82(6).
Stanton AL, Morra ME, Diefenbach MA, Miller SM, Slevin Perocchia R, Raich PC, Fleisher L, Wen KY, Tran ZV, Mohamed NE, George R, Bright MA, Marcus AC. Responding to a significant recruitment challenge within three nationwide psychoeducational trials for cancer patients. Journal of cancer survivorship : research and practice 2013 Sep; 7(3).
Wu LM, Mohamed NE, Winkel G, Diefenbach MA. Patient and spouse illness beliefs and quality of life in prostate cancer patients. Psychology & health 2013; 28(4).
Mohamed NE, Diefenbach MA, Goltz HH, Lee CT, Latini D, Kowalkowski M, Philips C, Hassan W, Hall SJ. Muscle invasive bladder cancer: from diagnosis to survivorship. Advances in urology 2012; 2012.
Diefenbach MA, Mohamed NE, Butz BP, Bar-Chama N, Stock R, Cesaretti J, Hassan W, Samadi D, Hall SJ. Acceptability and preliminary feasibility of an internet/CD-ROM-based education and decision program for early-stage prostate cancer patients: randomized pilot study. Journal of medical Internet research 2012 Jan; 14(1).
Lavery HJ, Levinson AW, Hobbs AR, Sebrow D, Mohamed NE, Diefenbach MA, Samadi DB. Baseline functional status may predict decisional regret following robotic prostatectomy. The Journal of urology 2012 Dec; 188(6).
Mohamed NE, Bovbjerg DH, Montgomery GH, Hall SJ, Diefenbach MA. Pretreatment depressive symptoms and treatment modality predict post-treatment disease-specific quality of life among patients with localized prostate cancer. Urologic oncology; 30(6).
Iberti C, Mohamed NE, Palese MA. A Review of Focal Therapy Techniques in Prostate Cancer: Clinical Results for High-Intensity Focused Ultrasound and Focal Cryoablation. Urology; 13(4).
Mohamed NE, Diefenbach MA. 1450 Differences between African American and white men in prostate cancer treatment-related expectations, worries, and decisional conflict and regret.. Journal of Urology; 185(4).
Diefenbach M, Mohamed NE, Horwitz E, Pollack A. Longitudinal associations among quality of life and its predictors in patients treated for prostate cancer: the moderating role of age. Psychology, health & medicine 2008 Mar; 13(2).
Diefenbach MA, Mohamed NE. Regret of treatment decision and its association with disease-specific quality of life following prostate cancer treatment. Cancer investigation 2007 Sep; 25(6).
Luszczynska A, Mohamed NE, Schwarzer R. Self-Efficacy and social support predict benefit finding 11 months after cancer surgery: The mediating role of coping.. Psychology, Health, and Medicine 2005; 10(3).
Schwarzer R, Böhmer S, Luszczynska A, Mohamed NE, Knoll N. Dispositional self-efficacy as a personal resource factor in coping after surgery.. Personality & Individual Differences; 39.
Mohamed NE, Böhmer S. A German translation of the Benefit Finding Scale: Adaptation und psychometric properties.. Medizinische Psychologie 2004; 13.
Schulz U, Mohamed NE. Turning the tide: benefit finding after cancer surgery. Social science & medicine (1982) 2004 Aug; 59(3).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Mohamed did not report having any of the following types of financial relationships with industry during 2016 and/or 2017: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.